Elias Kouchakji | Vice President Of Clinical Development And Drug Safety
Fibro Gen

Elias Kouchakji, Vice President Of Clinical Development And Drug Safety, Fibro Gen

Appearances:



World Drug Safety Congress USA 2019 - Day 1 @ 13:40

7) Emerging Markets - Implementing Infrastructure: the benefits of improving safety, incorporating Corporate Social Responsibility, and lowering long term cost

last published: 17/Apr/19 11:55 GMT

back to speakers

Get Involved At World Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Joseph Sica
joseph.sica@terrapinn.com
t/ +1 646 619 1839

 

 

 

To Speak


Michaela Deitrick
michaela.deitrick@terrapinn.com
t/ +1 646 619 1799

 

 

 

To Register


Joe McManus
joseph.mcmanus@terrapinn.com
t/ +1 646 619 1774